Search clinical trials for: Direct Oral Anticoagulant

Total 28830 results

Sanofi Pasteur, a Sanofi Company

Recruiting

Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers (CORAL)

RSV Immunization

United States
VarmX B.V.

Recruiting

Single Dose Trial of VMX-C001 in Healthy Subjects With and Without FXa Direct Oral Anticoagulant

Coagulation Disorder

Netherlands
Peking Union Medical College Hospital
Xiangya Hospital of Central South University; Ruijin Hospital; China-Japan Friendship...

Recruiting

The Study of Monitoring and Dosing Guidance of Direct Oral Anticoagulants Based on Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics

Pulmonary Embolism

China
Walton Centre NHS Foundation Trust
University of Liverpool; National Institute for Health Research, United Kingdom

Not yet recruiting

Timing to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemorrhage (RESTARTtlCrH)

Traumatic Intracranial Haemorrhage
Istituti Clinici Scientifici Maugeri SpA
Società Italiana Cardiologia Ospedalità Accreditata (SICOA)

Recruiting

Therapeutic Strategy With Direct Oral Anticoagulants and Antiaggregant Drugs in Ischemic Heart Disease (PRODOAC)

Atrial Fibrillation

Italy
Scott C. Woller, MD
Janssen Pharmaceuticals

Not yet recruiting

Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism (eVTE)

Deep Vein Thrombosis | Hospitalism | Venous Thromboembolic Disease | Pulmonary Embolism and Thrombosis

United States
Hôpital NOVO

Recruiting

Assessment of a Procedure for Managing Oral Anticoagulants (NACO) in the Management of Fractures (STOP-NACO)

Femur Fracture

France
Seoul National University Hospital
Medtronic Korea Co., Ltd.; Samjin Pharmaceutical Co., Ltd.

Not yet recruiting

Pill-in-the-POCKET Oral Anticoagulation Strategy After AF Catheter Ablation (POCKET-OAC)

Atrial Fibrillation
University Hospital, Angers

Not yet recruiting

RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing (RIVACAST)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism | Thromboprophylaxis | Lower Limb Trauma | Immobilisation

France
Peking Union Medical College Hospital

Recruiting

Rivaroxaban in Elderly Chinese Venous Thromboembolism Patients

Venous Thromboembolism | Pulmonary Embolism | Anticoagulant-induced Bleeding

China
University Hospital, Strasbourg, France

Recruiting

Thrombophilia Assessment Under DOAC: Effectiveness of Activated Charcoal (DOAC-Stop)

Thrombophilia

France
National Taiwan University Hospital

Recruiting

Evaluataion of NOAC Levels in Acute Stroke

Ischemic Stroke | Anticoagulant Adverse Reaction

Taiwan
University of Utah
National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting

Learning Theory Patient Education for Anticoagulants

Knowledge, Attitudes, Practice
University of Giessen

Recruiting

Urin-based Point-of-Care Testing for Direct Oral Anticoagulants in Stroke Patients (UPTURN)

Stroke

Germany
Insel Gruppe AG, University Hospital Bern

Not yet recruiting

Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy (ELAPSE)

Ischemic Stroke | Atrial Fibrillation
Centre Hospitalier Universitaire de Nīmes

Recruiting

Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus (ARGONAUT)

Heart Failure | STEMI | Intracardiac Thrombus

France, Réunion
Peking University First Hospital

Not yet recruiting

Imapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study II

Bleeding | Pharmacodynamics | Apixaban | Pharmacogenomics | Biomarker | Ticagrelor | Rivaroxaban | Novel Oral Anticoagulants | NOACs | Dabigatran | Edoxaban | RNA Profile

China
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

DOCE Study Interaction Between Direct Oral Anticoagulants and Drug-metabolizing Enzyme Inducers

Atrial Fibrillation | Thromboembolism, Venous

Italy
Mansoura University

Not yet recruiting

Efficacy of Direct Oral Anticoagulants as a Prophylactic Anticoagulation of Catheter Induced Thrombosis

Anticoagulants; Increased
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

DIrect Oral Anticoagulation and mechaNical Aortic Valve (DIAMOND)

Aortic Valve Disease

France
Centre Hospitalier Universitaire de Saint Etienne
Ministry of Health, France

Recruiting

Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets (BAT-VTE)

Venous Thromboembolic Disease

France
Janssen Research & Development, LLC

Recruiting

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (PALOMA-2)

Carcinoma, Non-small-Cell Lung

United States, Korea, Republic of, Italy, Israel, Malaysia, United Kingdom, China, Brazil, Spain, Germany, Japan, France
Sunnybrook Health Sciences Centre

Recruiting

Anticoagulation Therapy Timing in Atrial Fibrillation After Acute and Chronic Subdural Hematoma (ATTAACH)

Atrial Fibrillation | Subdural Hematoma

Canada
Centre Hospitalier Universitaire, Amiens

Recruiting

Adherence to Oral Anticoagulants in Patients With Atrial Fibrillation (3AOD)

Adherence | Oral Anticoagulant

France
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France; W.L.Gore & Associates; Abbott; Centre Hospitalier St... and other collaborators

Not yet recruiting

PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years (CLOSE-2)

Patent Foramen Ovale | Cryptogenic Ischemic Stroke

France
Clinical Hospital Centre Zagreb
Croatian Science Foundation; University of Zagreb School of Medicine

Recruiting

Pharmacogenomics in Prediction of Cardiovascular Drugs Adverse Reaction

Drug-Related Side Effects and Adverse Reactions | Pharmacogenetics | Cardiovascular Drugs

Croatia
Hospital Universitario La Fe

Recruiting

Uninterrupted Direct-acting Oral Anticoagulation in Patients Undergoing Transradial Percutaneous Coronary Procedures (DOAC-NOSTOP)

Coronary Artery Disease | Bleeding | Direct Acting Anticoagulant Adverse Reaction

Spain, Italy
Bristol-Myers Squibb

Recruiting

A Study Evaluating the Associations Between Clinical Characteristics and Use of Oral Anticoagulants in Italian Elderly Participants With Non-Valvular Atrial Fibrillation (PRESBUS)

Non-Valvular Atrial Fibrillation (NVAF)

Italy
University Hospital, Brest

Recruiting

AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms (AVAJAK)

Polycythemia Vera | Essential Thrombocythemia | High-risk Patients | Prefibrotic/Early Primary Myelofibrosis | JAK2 V617F

France
Chinese University of Hong Kong

Recruiting

A Trial on Prophylactic Clipping to Prevent Post-polypectomy Bleeding After Colonoscopy in Direct Oral Anticoagulant Users (PROCLIP)

Post Polypectomy Bleeding

Hong Kong
Takeda
Takeda Development Center Americas, Inc.

Recruiting

A Study of TAK-330 for Reversal of Direct Oral Factor Xa Inhibitor-induced Anticoagulation

Coagulation Disorder

United States, Spain, Belgium, France, Netherlands
Insel Gruppe AG, University Hospital Bern

Recruiting

Cohort of Patients With Left Ventricular Thrombus: Management and Outcomes in the Direct Oral Anticoagulants Era (LV-Thrombus)

Thrombus of Left Ventricle

Switzerland
André Luiz Malavasi Longo de Oliveira
Science Valley Research Institute

Recruiting

Venous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs Enoxaparin (VALERIA)

Cancer | Venous Thromboembolism | Rivaroxaban | Thromboprophylaxis

Brazil
University Hospital, Geneva
Sunnybrook Health Sciences Centre

Not yet recruiting

The API-CALF Study: Apixaban to Treat Calf Vein Thrombosis (API-CALF)

Deep Vein Thrombosis
Zuyderland Medisch Centrum

Not yet recruiting

Comparison Between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary Intervention (SLIM-2)

Coronary Artery Disease | Atrial Fibrillation | Anticoagulants
University Hospital Inselspital, Berne
Centre Hospitalier Universitaire Vaudois

Recruiting

Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis

Liver Cirrhosis

Switzerland
Octapharma

Recruiting

Study of OCTAPLEX in Patients With Acute Major Bleeding on DOAC Therapy With Factor Xa Inhibitor

Acute Major Bleeding

United States, Spain, Bosnia and Herzegovina, Croatia, Georgia, Italy, Poland, Germany, Turkey, United Kingdom, Ukraine, France, Austria
University of Birmingham
Royal United Hospitals Bath NHS Foundation Trust; Cimar

Recruiting

STOPping Anticoagulation for Isolated or Incidental Subsegmental Pulmonary Embolism (STOPAPE)

Subsegmental Pulmonary Embolism Nos

United Kingdom
University of Birmingham
University of Oxford; University Hospital Birmingham NHS Foundation Trust; London... and other collaborators

Recruiting

Preventing Stroke, Premature Death and Cognitive Decline in a Broader Community of Patients With Atrial Fibrillation (DaRe2THINK)

Atrial Fibrillation

United Kingdom
Wuhan Asia Heart Hospital
Wuhan Asia General Hospital (http://wagh.com.cn)

Not yet recruiting

Laboratory Assessment of the Concentration of Direct Oral Anticoagulants in Patients With Atrial Fibrillation (LOAF)

Atrial Fibrillation | Oral Anticoagulant | Pharmacokinetics and Pharmacodynamics
University Hospital Tuebingen
Heart and Diabetes Center North Rhine-Westphalia

Recruiting

Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants Extended (POCT-DOAC ext)

Anticoagulation With Direct Oral Anticoagulants

Germany
Direction Centrale du Service de Santé des Armées

Recruiting

Pilot Study: Comparison of Patients' Knowledge of Direct Oral Anticoagulants in Post-hospitalization Between 2 Cardiology Departments Offering or Not a Pharmaceutical Interview During Hospitalization (EDUC-AOD)

Atrial Fibrillation | Deep Vein Thrombosis | Pulmonary Embolism

France
Academisch Medisch Centrum - Universiteit van Amsterdam...
Sahlgrenska University Hospital, Sweden; University of Helsinki; Hospital de...

Recruiting

Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis (DOAC-CVT)

Cerebral Venous Thrombosis

Netherlands
Benjamin Viglianti

Recruiting

Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Groups 2, 3 & 4)

Hypertension | Cholesterol | Radiotracer

United States
AHEPA University Hospital
Theagenio Cancer Hospital

Recruiting

Management of Atrial Fibrillation in Patients With Cancer (MAFIC Study) (MAFIC)

Cancer | Atrial Fibrillation

Greece
St. Antonius Hospital
Daiichi Sankyo, Inc.

Recruiting

What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI? (WOEST-3)

Myocardial Infarction | Coronary Artery Disease | Stroke | Embolism | Atrial Fibrillation | Bleeding | Acute Coronary Syndrome | Atrial Flutter | NSTEMI - Non-ST Segment Elevation MI | Stent Thrombosis | STEMI - ST Elevation Myocardial Infarction

Belgium, Netherlands
Hospital Álvaro Cunqueiro

Recruiting

Retrospective Observational Registry of Patients With Atrial Fibrillation From Vigo´s Health Area (CardioCHUVI-AF)

Atrial Fibrillation

Spain
Population Health Research Institute
Hamilton Health Sciences Corporation

Recruiting

The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial (DANCE)

Bleeding Post Cardiac Surgery | Indication for Anticoagulation

Canada
Stéphane Zuily
International Society on Thrombosis and Haemostasis

Recruiting

International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants (OBSTINATE)

Thrombosis | Antiphospholipid Syndrome | Anticoagulants Causing Adverse Effects in Therapeutic Use

France
Northwestern University
National Cancer Institute (NCI)

Recruiting

Ivosidenib and Combination Chemotherapy for the Treatment of IDH1 Mutant Relapsed or Refractory Acute Myeloid Leukemia

Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | Recurrent Myeloproliferative Neoplasm

United States

Search clinical trials for: Direct Oral Anticoagulant

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations